Metynodiol diacetate
![]() | |
| Identifiers | |
|---|---|
| |
| Synonyms | (3β,11β,17α)-11-Methyl-19-norpregn-4-en-20-yne-3,17-diyl diacetate; (3β,11β,17β)-17-ethynyl-11-methyl-estr-4-ene-3,17-diol diacetate |
| CAS Number | 23163-51-1 |
| PubChem (CID) | 10408585 |
| ChemSpider | 8584022 |
| UNII | 2BC0LM6I2M |
| KEGG | D05003 |
| ChEMBL | CHEMBL2106950 |
| Chemical and physical data | |
| Formula | C25H34O4 |
| Molar mass | 398.53506 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Methynodiol diacetate (USAN) (developmental code name SC-19198), or metynodiol diacetate, also known as 11β-desmethyletynodiol diacetate, is a steroidal progestin of the 19-nortestosterone group that was patented in 1968 but was never marketed.[1] It is the diacetate ester of metynodiol, which, similarly, was never marketed.[1]
See also
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 820–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
